Premier Biomedical, Inc. (BIEI)
OTCMKTS: BIEI · Delayed Price · USD
0.0008
-0.0001 (-6.25%)
Jul 19, 2024, 4:00 PM EDT - Market open
Premier Biomedical Market Cap
Premier Biomedical has a market cap or net worth of $749.99 thousand as of July 22, 2024. Its market cap has increased by 150.00% in one year.
Market Cap
749.99K
Enterprise Value
1.31M
1-Year Change
150.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since August 15, 2012, Premier Biomedical's market cap has decreased from $14.60M to $749.99K, a decrease of -94.86%. That is a compound annual growth rate of -33.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 6, 2019 | 200.00K | -33.33% |
| Dec 31, 2018 | 300.00K | -85.71% |
| Dec 29, 2017 | 2.10M | 90.91% |
| Dec 30, 2016 | 1.10M | -56.00% |
| Dec 31, 2015 | 2.50M | 4.17% |
| Dec 31, 2014 | 2.40M | -82.22% |
| Dec 31, 2013 | 13.50M | 21.62% |
| Dec 31, 2012 | 11.10M | -23.97% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |